Verastem, Inc. (VSTM)
7.615
+0.40
(+5.47%)
USD |
NASDAQ |
Sep 01, 16:00
7.61
0.00 (0.00%)
After-Hours: 20:00
Verastem Cash from Operations (TTM) : -162.20M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -162.20M |
| March 31, 2026 | -150.95M |
| December 31, 2025 | -137.51M |
| September 30, 2025 | -132.65M |
| June 30, 2025 | -120.23M |
| March 31, 2025 | -115.14M |
| December 31, 2024 | -104.77M |
| September 30, 2024 | -109.35M |
| June 30, 2024 | -102.15M |
| March 31, 2024 | -94.48M |
| December 31, 2023 | -86.46M |
| September 30, 2023 | -73.40M |
| June 30, 2023 | -71.89M |
| March 31, 2023 | -64.68M |
| December 31, 2022 | -63.67M |
| September 30, 2022 | -56.99M |
| June 30, 2022 | -52.74M |
| March 31, 2022 | -53.46M |
| December 31, 2021 | -53.50M |
| September 30, 2021 | -65.27M |
| June 30, 2021 | -11.46M |
| March 31, 2021 | -20.58M |
| December 31, 2020 | -35.27M |
| September 30, 2020 | -51.22M |
| June 30, 2020 | -122.06M |
| Date | Value |
|---|---|
| March 31, 2020 | -134.18M |
| December 31, 2019 | -138.96M |
| September 30, 2019 | -120.48M |
| June 30, 2019 | -115.20M |
| March 31, 2019 | -90.84M |
| December 31, 2018 | -74.52M |
| September 30, 2018 | -75.65M |
| June 30, 2018 | -64.94M |
| March 31, 2018 | -69.11M |
| December 31, 2017 | -57.31M |
| September 30, 2017 | -42.94M |
| June 30, 2017 | -37.10M |
| March 31, 2017 | -29.31M |
| December 31, 2016 | -29.48M |
| September 30, 2016 | -33.74M |
| June 30, 2016 | -39.33M |
| March 31, 2016 | -44.65M |
| December 31, 2015 | -45.56M |
| September 30, 2015 | -45.01M |
| June 30, 2015 | -42.65M |
| March 31, 2015 | -39.35M |
| December 31, 2014 | -36.90M |
| September 30, 2014 | -33.79M |
| June 30, 2014 | -31.64M |
| March 31, 2014 | -29.24M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 160.32M |
| Dianthus Therapeutics, Inc. | -155.38M |
| Alnylam Pharmaceuticals, Inc. | 885.89M |
| Anika Therapeutics, Inc. | 5.977M |
| Savara, Inc. | -110.38M |